This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WebMD acquired the operating assets of Healthwise, a nonprofit provider of health education content and patient engagement tools. The deal follows another acquisition WebMD made in the patient engagement space in 2020.
If organizations present medical records, cost data, and descriptions of billing codes to patients without providing context or stripping out medical jargon, then the information is potentially subject to regulatory penalties. That means providing more patient-friendly terminology is more than just a compliance checkbox.
In just 2020, deaths from gun violence cost the U.S. healthcare system $290 million, or about $6,400 per patient, according to a report from the Commonwealth Fund. These costs are mostly covered by Medicaid and other government insurance programs.
In 2020, 46.9% of all novel drugs approved by the FDA were for rare diseases, as compared to 23.5% Investment is expected to continue trending upward, with estimates suggesting that global spending on rare disease therapies will reach $260 billion by the end of 2025.
GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.
Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday.
ReKlame Health launched in 2020 to provide affordable, culturally competent behavioral healthcare to Black and Brown communities in New York. On Monday, the startup announced it is now serving patients in two additional states — New Jersey and Florida.
Do patients care? Do patients care? 85% of accelerated approvals from 2010 to 2020 were for oncology indications. If you’re a cancer patient and your oncologist is prescribing a drug approved via accelerated Approval, are you going to refuse treatment? The post Do patients care about accelerated approval drugs?
From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2 The drug industry is driven by profits, not by patient’s needs.
IN SUMMARY : When patients return to doctor’s offices will HCP’s have time to go online with every drug company that requests an online detail? Will patients be happy with telehealth once they feel it’s safe to return to physicians’ offices? As for patients?
(Stat News) Today, a study followed 380 patients being treated at community oncology groups across the U.S. Patients who experience financial hardship during cancer treatment are at higher risk for treatment nonadherence, poor quality of life, and worse survival. billion in 2020 (2020 U.S. lost work and income).
SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?
And, it can increase patient volume and revenue. And when woven into your content marketing strategy, a strong value proposition becomes essential for increasing patient volume and revenue in the healthcare industry. That’s why your value proposition is crucial for attracting new patients and ensuring long-term loyalty.
billion in 2020 to a projec | A phase 3 study has shown that a new, subcutaneous version of Roche's Ocrevus has proven to be non-inferior to the current infused treatment as measured by the level of drug in the blood, 12 weeks after administration. With the multiple sclerosis market growing rapidly—from $18.9
According to the Lancet, a medical journal, the incidence of depression and anxiety has soared in the pandemic—by more than 25% globally in 2020. In October 2020, hackers who had breached Vastaamo, a famous Finnish startup, began blackmailing its users. But are they safe and effective? And then there are the pesky privacy issues.
Maximizing the Impact of Patient Support Programs through Strategic Branding A pharmaceutical company is powered by their portfolio of product brands, but can reach new heights by servicing patients, engaging prescribers, and driving better health outcomes. Today, nearly all product brands offer some degree of customer service.
In April 2020, 43.5% Compared with the overall population in these 20 states, DTC telemedicine patients were more likely to live in urban areas (85.0% 14.8%) were for patients living in a primary care health professional shortage area. Pharma’s content needs to focus on helping patients rather than selling them.
DTC marketers who believe that DTC is essentially the same as before the pandemic are failing to recognize significant shifts in patient behavior regarding prescription drugs. In an era of a pandemic, are psoriasis patients really going to ask for a drug that may compromise their immune system? What are other patients saying about it?
According to a new report , life expectancy in the United States took another hit in 2021, furthering a dramatic decline from 2020 that was the largest since World War II. years in 2020 and 76.60 In contrast, peer countries averaged a smaller decrease in life expectancy between 2019 and 2020 (0.57 years in 2019 to 76.99
2020 trend concept. Hand flip wood cube change year 2019 to 2020. In my opinion, this is due to pharma being sold on programmatic and the lack of investment in creative. 9ine: Searches for specific medical terms have increased, indicating that people don’t necessarily understand common medical terms.
Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with the autoimmune disorder systemic lupus erythematosus (SLE). The post Akili digital therapeutic shows promise in lupus patients appeared first on.
By the look of 2020’s results, he’s on the right track—and his compensation shows it. For 2020, AbbVie’s handing its longtime CEO $24 million in total pay, up from 2019’s $21.6 million, the company disclosed in a proxy filing” No biosimilar will take on Humira’s $16 billion in 2020 U.S.
Digital health companies aim to address the numerous health care challenges, including poor patient engagement, communication gaps between patients and providers, lack of longitudinal data, inconvenience of care delivery, and insufficient clinical decision support for providers and patients. What about patients?
3 Significant unmet needs The path to diagnosis of a rare disease is complex, taking on average five to eight years from the onset of symptoms before a patient receives an accurate diagnosis. Even with a diagnosis, patients continue to face barriers to care. Engaging with patients and caregivers is key to addressing these challenges.
A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 Adding sales and medical support staff is expensive, not to mention the cost of “marketing” the drug to patients and consumers.
Aggregate visit volumes for telehealth and in-person Primary Care visits in October 2020 were 7% lower than the volume of solely in-person Primary Care visits for October 2019. Before and after the onset of the COVID-19 pandemic, Behavioral Health accounted for the most significant share of telehealth visits. On average, in 2021, 57.9%
It’s hard not to read a story about how high drug prices are hurting patients, but while drug prices are too high and outpacing inflation, insurers, PBMs, and hospitals are taking huge slices of healthcare dollars with little notice from Congress and the media. or more – the current annual inflation rate. . million people have died.
anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. Health insurers have started effectively stealing co-pay coupons, leaving patients on the hook for far higher expenses. These pricing scams hurt patients as well.
I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.
billion alliance with Genmab signed in 2020 – can be used to treat adults with DLBCL whose cancer has returned or has not responded to at least two previous systemic treatments. Tepkinly (epcoritamab) – the first medicine to emerge from AbbVie’s $3.9
Doctors using telemedicine software are not sure of its value to patients and believe telehealth may pose risks. As one thought leader told me, “I need to see patients in person when they come in for a specific problem.” from 2020 to 2027. The hype around telehealth has followed a projected pattern.
According to a recent survey of patient groups, Roche, Pfizer, ViiV Healthcare and Gilead Sciences are among the top companies for implementing and reporting progress on environmental, social, governance (ESG) activities.
Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. In 2020, among the 52.9 In-person is always better but may be embarrassing to some but can an online therapist treat patients?
Following the impact of the COVID pandemic in 2020, patient engagement has become the focus area for more than half of healthcare chief information officers (CIOs). At the same time, patient portals have always been considered one of the most efficient tools for patient engagement. Explaining Medication Action.
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
Data show a roughly 46 percent combined decrease in weekly new diagnoses across six different cancers, according to a study published in August 2020 in JAMA Network Open. Physicians should be reminding their patients of the importance of early cancer screening, especially for high-risk patients.
million in 2020). Any therapy that is not face to face, such as texting, Emailing, and chat, robs patients of a vitally important means of communication. The Federal Government has a list of laws to protect patient privacy. Mental illnesses are common in the United States. Nearly one in five U.S. These laws are called HIPPA.
In 2020, there should be over 592 million daily app downloads, and a survey by Gallup revealed that nearly half (45%) of Americans have at least tried digital health products such as fitness trackers or mobile health apps.Indeed, 1 in 5 (20%) have tried or are using both fitness trackers and apps. Sleep monitoring. This is new to pharma.
However, these numbers escalated in 2020, along with the COVID-19 pandemic. Negative or angry emotions According to her survey of 70,000 “The Mighty” readers and community members, the number of people choosing anger as their top emotion more than doubled from March to September 2020— rising from 20% to 45%. How did we get here?
Among their findings: Downloads of apps supporting consumers with mental health needs increased by nearly 200% from summer 2019 to summer 2020 Downloads of those supporting consumers with diets and weight loss rose by a massive 1294% from mid-2019 to mid-2020. What happens when AI/digital health harms patients? 3hree: Oops !
AbbVie, Humira’s manufacturer, kicked off 2020 with a price increase in excess of 7 percent on its mega-blockbuster brand-name treatment. AbbVie significantly inflated prices over the past two decades for patients in the U.S. Sales of Humira earned AbbVie $20.7 Richard Gonzalez, C.E.O. So how do people who work for AbbVie feel?
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content